发明授权
- 专利标题: Enzyme gene and its expression product
- 专利标题(中): 酶基因及其表达产物
-
申请号: US10297599申请日: 2001-06-12
-
公开(公告)号: US07091018B2公开(公告)日: 2006-08-15
- 发明人: Tsutomu Fujiwara , Takashi Okamoto , Masashi Niimi , Hiroyuki Kyushiki , Yasuchika Yamamoto , Atsunori Ueyama
- 申请人: Tsutomu Fujiwara , Takashi Okamoto , Masashi Niimi , Hiroyuki Kyushiki , Yasuchika Yamamoto , Atsunori Ueyama
- 申请人地址: JP Tokyo
- 专利权人: Otsuka Pharmaceutical Co., Ltd.
- 当前专利权人: Otsuka Pharmaceutical Co., Ltd.
- 当前专利权人地址: JP Tokyo
- 代理机构: Oblon, Spivak, McClelland, Maier & Neustadt, P.C.
- 优先权: JP2000-176631 20000613; JP2000-290679 20000925
- 国际申请: PCT/JP01/04941 WO 20010612
- 国际公布: WO01/96574 WO 20011220
- 主分类号: C12N9/10
- IPC分类号: C12N9/10 ; C12N1/12 ; C12N15/00 ; C07H21/04
摘要:
The present invention is drawn to a gene comprising a polynucleotide encoding a polypeptide composed of an amino acid sequence represented by SEQ ID NO: 1; a gene expression product produced through expression of the gene; a recombinant expression vector including the gene; a host cell (transformant) harboring the recombinant expression vector; a protein composed of an amino acid having an amino acid sequence represented by SEQ ID NO: 1; a therapeutic or preventive composition for hypoglycemia containing as an active ingredient the above-mentioned gene or protein; and an antibody capable of binding to the protein. Through use of the gene or an expression product thereof of the present invention, it is possible to elucidate the pathology of diabetes and develop drugs for treatment and prevention of diabetes via a new action mechanism.
公开/授权文献
- US20040132020A1 Novel enzyme gene and its expression product 公开/授权日:2004-07-08
信息查询